Clinical Diagnostics and Research Tools Market Research Reports

  1. 30 Dec 2022  |  North America  |  Market Research

    Trends and Growth Indicators for Physician Offices/labs in Decentralized Testing and Services

    Personalized Diagnostics Are at the Cusp of Transformational Growth

    Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...

    $2,450.00
  2. 19 Dec 2022  |  North America  |  Market Research

    PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

    Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem

    Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

    $2,450.00
  3. 19 Dec 2022  |  North America  |  Market Outlook

    Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

    An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

    $2,450.00
  4. 01 Dec 2022  |  North America  |  Market Research

    Global in Vitro Fertilization Services Growth Opportunities

    Disruptive Technologies and Innovative Business Models are the Key Drivers in the IVF Services Industry

    This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...

    $4,950.00
  5. 03 Oct 2022  |  Global  |  Market Research

    Global Prenatal Genetic Testing—Forecast to 2026

    Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

    New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help...

    $4,950.00
  6. 22 Sep 2022  |  North America  |  Market Research

    AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics

    Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade

    Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

    $2,450.00
  7. 23 Aug 2022  |  North America  |  Frost Radar

    Frost Radar™: US Liquid Biopsy, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

    $4,950.00
  8. 14 Mar 2022  |  North America  |  Market Outlook

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

    $4,950.00
  9. 01 Mar 2022  |  Europe  |  Market Research

    European Clinical Laboratory Services Growth Opportunity

    Customer Experience Driven by New B2B and B2C Business Models

    Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or sur...

    $2,450.00
  10. 28 Feb 2022  |  North America  |  Market Research

    United States Clinical Laboratory Services Growth Opportunities

    Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites

    The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...

    $2,450.00